Plasma adenosine 3′, 5′-cyclic monophosphate: Dose-response to injected bovine parathyroid hormone in man

1976 ◽  
Vol 22 (S1) ◽  
pp. 332-335 ◽  
Author(s):  
I. G. Lewin ◽  
G. N. Hendy ◽  
S. E. Papapoulos ◽  
S. Tomlinson ◽  
J. L. H. O'Riordan
1974 ◽  
Vol 2 (3) ◽  
pp. 453-455 ◽  
Author(s):  
PETER M. BARLING ◽  
JANET D. M. ALBANO ◽  
STEPHEN TOMLINSON ◽  
BARRY L. BROWN ◽  
J. L. H. O'RIORDAN

1974 ◽  
Vol 47 (5) ◽  
pp. 481-492 ◽  
Author(s):  
S. Tomlinson ◽  
P. M. Barling ◽  
J. D. M. Albano ◽  
B. L. Brown ◽  
J. L. H. O'Riordan

1. Administration of highly purified bovine parathyroid hormone (BPTH) (200 MRC units) increased the concentration of adenosine 3′,5′-cyclic monophosphate (cyclic AMP) in the peripheral plasma of normal subjects within minutes, whether the hormone was given as a bolus injection or an infusion. 2. The subsequent disappearance of cyclic AMP from the circulation was also rapid (t1/2 = 14 min) and was associated with a prompt decline (t1/2 = 4.6 min) in the concentration of the ammo-terminal part of BPTH, as measured in a region-specific immunoradiometric assay. 3. The concentration of cyclic AMP in plasma from a renal vein was found to increase more rapidly and to reach a greater peak than plasma from a peripheral vein. 4. The administration of BPTH to anephric subjects caused no increase in cyclic AMP. 5. These investigations indicate that parathyroid hormone can act extremely rapidly, with a short half-life, and that the kidney makes a major contribution to the changes in plasma cyclic AMP induced by the hormone. In addition, they form the basis for the development of a simplified Ellsworth—Howard test, using changes in circulating cyclic AMP after BPTH administration as an index of responsiveness to the hormone.


1982 ◽  
Vol 62 (4) ◽  
pp. 381-387 ◽  
Author(s):  
I. G. Lewin ◽  
S. E. Papapoulos ◽  
G. N. Hendy ◽  
S. Tomlinson ◽  
J. L. H. O'riordan

1. The response to exogenous parathyroid hormone (PTH) was tested in normal subjects and patients with osteomalacia due to vitamin D deficiency; 200 MRC units of bovine PTH were administered intravenously. 2. The rise in plasma adenosine 3′:5′-cyclic monophosphate (cyclic AMP) and the increase in urinary excretion of cyclic AMP were reduced in the patients with vitamin D deficiency. After treatment with vitamin D the responses returned to normal. 3. It is suggested that this reversible resistance is due to the secondary hyperparathyroidism associated with vitamin D deficiency.


PLoS ONE ◽  
2015 ◽  
Vol 10 (3) ◽  
pp. e0120402 ◽  
Author(s):  
Shuangxin Liu ◽  
Weiping Zhu ◽  
Sijia Li ◽  
Tongxia Cui ◽  
Zhonghe Li ◽  
...  

Metabolism ◽  
1975 ◽  
Vol 24 (2) ◽  
pp. 139-144 ◽  
Author(s):  
Frederick R. Singer ◽  
Gino V. Segre ◽  
Joel F. Habener ◽  
John T. Potts

2011 ◽  
pp. S60-1-S60-1
Author(s):  
J Christopher Gallagher ◽  
Adarsh Sai ◽  
Thomas J Templin ◽  
Lynette M Smith

1971 ◽  
Vol 49 (3) ◽  
pp. 521-530 ◽  
Author(s):  
G. M. ADDISON ◽  
C. N. HALES ◽  
J. S. WOODHEAD ◽  
J. L. H. O'RIORDAN

SUMMARY An immunoradiometric assay for parathyroid hormone has been developed. Antisera to bovine parathyroid hormone (BPTH) were screened for their ability to bind BPTH and human parathyroid hormone (HPTH). A BPTH-immunoadsorbent was used to extract antibodies from an antiserum which did not discriminate between BPTH and HPTH in a standard radioimmunoassay. These antibodies were labelled with 125I for use in the immunoradiometric assay. With this system as little as 5 pg BPTH and 8 pg HPTH could be detected. The serum concentration of BPTH was shown to rise in a cow rendered hypocalcaemic by an infusion of EDTA. Sera from patients with hyperparathyroidism contained high concentrations of hormone. These sera were found to dilute-out parallel to calibration curves obtained using HPTH extracted from parathyroid adenomata. The advantages of this method over the standard radioimmunoassay are discussed.


Sign in / Sign up

Export Citation Format

Share Document